Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.

Yu, Fei; Xue, Yanfeng; Zhao, Yunyan; Zhang, Long; He, Xiao; Liu, Zheng

Yu, Fei; Xue, Yanfeng; Zhao, Yunyan; Zhang, Long; He, Xiao; Liu, Zheng.

Afiliação

Yu F; Department of Traditional Chinese Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, P.R. China.
Xue Y; Department of Traditional Chinese Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, P.R. China.
Zhao Y; Department of Traditional Chinese Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, P.R. China.
Zhang L; Department of Traditional Chinese Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, P.R. China.
He X; Department of Traditional Chinese Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, P.R. China.
Liu Z; Department of Traditional Chinese Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, P.R. China.

Gynecol Endocrinol ; 39(1): 2183045, 2023 Dec.

Article em En | MEDLINE | ID: mdl-36842967

Assuntos

Síndrome do Ovário Policístico; Animais; Feminino; Ratos; Peso Corporal; Desidroepiandrosterona/farmacologia; Hormônio Foliculoestimulante; Insulina; Hormônio Luteinizante; Síndrome do Ovário Policístico/induzido quimicamente; Síndrome do Ovário Policístico/tratamento farmacológico; Ratos Sprague-Dawley; Receptores Tipo I de Fatores de Necrose Tumoral/efeitos adversos; Testosterona; Fator de Necrose Tumoral alfa

Palavras-chave

Polycystic ovary syndrome; TNF signaling pathway; apoptosis; inflammatory response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google